A system and method for treating anorectal and/or genitourinary dysfunction includes implanting, in a minimally invasive manner, an electro-medical device for stimulation of two or more anatomical or histological structures of the anorectal region and/or genitourinary region. Electrodes operably connected to the device are positioned proximate the target anatomical or histological structures. The device provides either the same or different stimulation algorithms to each anatomical or histological structure, which may be the same or different. The varied stimulation parameters, such as pulse width, pulse amplitude, and pulse frequency, are defined such that after an application of the electrical pulses, an abdominal leak pressure, an abdominal leak volume, or a urine volume increases or a number of incontinent episodes or a mean incontinence volume per episode decreases relative to said parameters prior to the application of the electrical pulses.

A hollowly cylindrical supporting body is used for an electrical stimulation probe, and the electrical stimulation probe provides an insulated outer shell. The insulated outer shell can accommodate and cover the hollowly cylindrical supporting body. Further, the hollowly cylindrical supporting body can be assembled precisely with the insulated outer shell through Fool-Proofing Design. Therefore, the insulated outer shell and the hollowly cylindrical supporting body can be combined closely and joined together to form the electrical stimulation probe of the present invention.

A device for stimulating nerves adjacent the vagina includes a nerve stimulating element coupled to a main body. The nerve stimulating element is positioned and designed to stimulate the vesical, Frankenhauser's and/or inferior hypogastric plexuses. The device may reside in the vaginal fornices. An implant is also provided which has a nerve stimulating element in contact with a uterosacral ligament. The device positioned in the vagina may be used to charge a power source for an implant which may be a capacitor.

There is disclosed a device and method for delivering constant target current to a muscle for electro-stimulation of that muscle. One device is a completely self-contained device with no external means for the adjustment and control of the electro-stimulation delivered to the muscle during treatment. The microprocessor based device monitors indirectly the actual current delivered to the muscle during electro-stimulation via measurement of the return path voltage through the muscle and optionally in addition monitors and adjusts for the internal battery voltage during use of the device in order to deliver a more consistent an accurate and effective target output current to the muscle being stimulated at each and every pulse delivered from the device. The device is pre-programmed with an electro-stimulation treatment cycle and the whole treatment cycle, including the monitoring and adjustment required to achieve this treatment cycle, is automatic within the device.

The present invention is a system and method for providing an electrical stimulation signal to condition the pelvic wall muscles of a user and demonstrate to the user the proper muscle usage. The system and method also provides a system for measuring the users muscle response. The system and method also provides an entertaining interaction environment which encourages the user to perform self-initiated conditioning exercises.

The present invention relates to method for implanting an apparatus for treating sexual dysfunction in a female patient. The apparatus has a stimulation device for stimulating an erectile blood flow passageway to increase the amount of blood in the female erectile tissue and thereby obtaining engorgement with blood of the female erectile tissue by affecting said erectile blood flow passageway.

A device for muscle training and treating urinary incontinence including a body configured for insertion intravaginally for placement within the vagina, at least one sensor supported on the body for measuring intra-abdominal pressure and at least one electrode supported on the body and in electrical communication with the at least one sensor. The at least one electrode sends an electrical signal to pelvic muscles of a user to contract the pelvic muscles based on feedback from the sensor. An electric signal generator housed within the body sends the electrical signal to the electrode. The device can also have application for treating fecal incontinence and pelvic floor weakness.

An intravaginal electrical stimulation device for treating pelvic pain in a female patient comprises a set of intravaginal components and an external controller. The intravaginal components include a frame, at least one pair of paracervical electrodes embedded in the proximal portion of the frame, an intravaginal capsule, an electrode plug that plugs into a socket in the proximal end of the capsule, and connecting wires that electrically couple the electrode plug to the paracervical electrodes. The intravaginal components are designed to inserted into the patient's vagina so that the paracervical electrodes are in direct contact with the vaginal epithelium in the lateral vaginal fornices. Electronics, including a microprocessor and an electrical stimulation generator, are configured to generate and transmit low-voltage electrical current to the paracervical electrodes to create an electrical field that neuromodulates the pelvic and paracervical nerves, the nerves that innervate the uterus, and other anatomical structures of the lower pelvis, which tends to reduce or eliminate pelvic pain. The set intravaginal components are configured so that a woman can easily insert them into her vagina (with or without a medical practitioner being present). The external controller, which communicates with the intravaginal components over a wireless data communication channel, sends instructions to and receives status updates from the microprocessor inside the intravaginal capsule. The external controller may be operated by the female patient to control the electrical profile (e.g., frequency, amplitude and duration) of the electrical stimulation delivered to her body, and thereby cause the intravaginal components to deliver well-controlled, personalized, electrical stimulation to her pelvic and paracervical nerves when she is experiencing pain, or when she anticipates the onset of pelvic pain due to, for example, menstruation or sexual intercourse.

The systems and methods described herein generally relate to adjusting a neurostimulation (NS) therapy based on drug pharmacokinetics of a patient. The systems and methods deliver an NS therapy to a portion of electrodes of a lead positioned proximate to neural tissue of interest, which is associated with a target region. The NS therapy is defined by stimulation parameters. The systems and methods determine a trigger event indicative of a drug being administered to a patient. The drug is configured to affect at least one of the neural tissue of interest or the target region. The systems and methods adjust one or more of the stimulation parameters based on the PS profile.

The present disclosure relates to neural electrode technology for measuring a biosignal of a human or applying a neural signal to the human, and a neural electrode assembly includes a body that is inserted into a uterus in a non-invasive manner, a recording neural electrode formed to measure a uterine contraction-evoked neural signal, the recording neural electrode being coupled to the body, and a stimulating neural electrode formed to stimulate a nerve entering the uterus to suppress the uterine contraction, the stimulating neural electrode being coupled to the body.